At the same time, some cellular components of TME secrete immune-suppressive factors such as TGF-β and IL-10, which inhibit the antitumor activity of immune cells in peripheral blood, helping tumor cells evade surveillance by the host immune system [74]. This evidence concerns the gene TGFB1 and neoplasm.